
Sign up to save your podcasts
Or
Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2501561
4.8
129129 ratings
Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2501561
134 Listeners
288 Listeners
318 Listeners
48 Listeners
498 Listeners
3,331 Listeners
90 Listeners
1,105 Listeners
22 Listeners
195 Listeners
517 Listeners
349 Listeners
182 Listeners
367 Listeners
79 Listeners